Results 201 to 210 of about 141,580 (256)

Lynch Syndrome as a Spectrum of Four Distinct Genetic Disorders: Toward Genotype-Guided Precision Management in the NGS Era. [PDF]

Cancers (Basel)
Liu Y, Ye S, Liu Z, Chen Z, Liang X.
europepmc   +1 more source

Germline BRCA2 Mutation and Lynch Syndrome in a Patient With Multiple Primary Malignancies. [PDF]

Case Rep Oncol Med
Puglisi MM, Dziarnowski NN, Baralo B, Vachhani H.   +3 more
europepmc   +1 more source

Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study. [PDF]

EClinicalMedicine
Negro S, Celotto F, Schiavi F, Scarpa M, Mammi I, Rossi S, Dell'Atti L, De Grandis MC, Crivellari G, Fassan M, Agostini M, Spolverato G, Cappello F, D'Angelo E, Milella M, Bencivenga M, Pilati P, Lonardi S, Intini R, Guarneri V, Dieci MV, Morabito A, Barana D, D'Urso A, Iafrate M, Bergamo F, Urso EDL.   +26 more
europepmc   +1 more source

Severe leukemoid reaction and spontaneous tumor lysis syndrome in a young patient with undifferentiated Lynch syndrome-associated ovarian cancer. [PDF]

Gynecol Oncol Rep
Watkins CMS, Allahifard M, Cattoni J, Montemorano L.   +3 more
europepmc   +1 more source

The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short Report. [PDF]

EJHaem
Oka T, Nakajima T, Iwasaki M, Takeda J, Torishima M, Sakurada M, Shimizu T, Shindo T, Fujimoto M, Otsuki S, Haga H, Sugano K, Ando M, Mizumoto C, Kanda J, Nannya Y, Ogawa S, Takaori-Kondo A, Kosugi S.   +18 more
europepmc   +1 more source

Integrative omics approaches to uncover liquid-based cancer-predicting biomarkers in Lynch syndrome. [PDF]

Int J Cancer
Kärkkäinen M, Sievänen T, Korhonen TM, Tuomikoski J, Pylvänäinen K, Äyrämö S, Seppälä TT, Mecklin JP, Laakkonen EK, Jokela T.   +9 more
europepmc   +1 more source

Integrative proteomics reveals mitochondrial and immune signatures of MLH1 exon 13 deletion in Lynch syndrome-associated colorectal cancer. [PDF]

Front Mol Biosci
Chang C, Cao Y, Zhang B, Chen J, Chen L, Li W, Wang G.   +6 more
europepmc   +1 more source

The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome-A prospective longitudinal study. [PDF]

Int J Cancer
van Liere ELSA, Ramsoekh D, Stewart TK, Daulton E, Jacobs MAJM, Dekker E, Bosch S, Covington JA, de Meij TGJ, de Boer NKH.   +9 more
europepmc   +1 more source

Canadian consensus for the assessment and testing of Lynch syndrome. [PDF]

J Med Genet
Aronson M, Palma L, Semotiuk K, Nuk J, Pollett A, Singh H, Rothenmund H, Racher H, Jessen J, Pautler SE, Rusnak A, Rutka M, Etchegary H, Tiano T, Kaurah P, Dawson L, Hawrysh A, Ward T, Bedard A, Sheffield BS, Lerner-Ellis J, Jacob K, Ferguson S, Kim CA, Chamberlain E, Dornan K, Waldman L, Holter S, Horte J, Hyde A, Kwon J, MacMillan A, O'Loughlin M, Tabori U, Gallinger S, Kim R.   +35 more
europepmc   +1 more source

Case Report: Unique immunotherapy response in a patient with metachronous colorectal cancer not associated with Lynch Syndrome. [PDF]

Front Oncol
Krishnamurthy N, Cohen D.
europepmc   +1 more source